{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:42:40Z","timestamp":1747165360376,"version":"3.40.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jmdjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jmoldx.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:05:14Z","timestamp":1719212714000},"page":"792-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-7552","authenticated-orcid":false,"given":"Cristina","family":"Iribarren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin H.","family":"Levedahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-6681","authenticated-orcid":false,"given":"Ionut","family":"Atanasoai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-8801","authenticated-orcid":false,"given":"Mattias","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stina","family":"S\u00f6derlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niclas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-5512","authenticated-orcid":false,"given":"Gunnar P.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2024.05.010_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/joim.12410","article-title":"Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease","volume":"279","author":"G\u00fclen","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib3","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01965102","article-title":"Increased urinary methylimidazoleacetic acid (MelmAA) as an indicator of systemic mastocytosis","volume":"12","author":"Granerus","year":"1982","journal-title":"Agents Actions"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib5","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJM198012113032405","article-title":"Increased production of prostaglandin D2 in patients with systemic mastocytosis","volume":"303","author":"Roberts","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib6","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jaip.2020.02.021","article-title":"The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome","volume":"8","author":"Butterfield","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib7","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1038\/s41598-022-08345-3","article-title":"SWATH-MS identification of CXCL7, LBP, TGF[beta]1 and PDGFR[beta] as novel biomarkers in human systemic mastocytosis","volume":"12","author":"Graham","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaci.2023.01.033","article-title":"Proteomic and transcriptomic screening demonstrates increased mast cell derived CCL23 in systemic mastocytosis","volume":"152","author":"S\u00f6derlund","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaci.2021.12.786","article-title":"Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis","volume":"150","author":"Hermans","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12167","article-title":"Altered innate immune profile in blood of systemic mastocytosis patients","volume":"12","author":"P\u00e9rez-Pons","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","volume":"30","author":"Mayado","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaci.2020.09.037","article-title":"Increased group 2 innate lymphoid cells in peripheral blood of adults with mastocytosis","volume":"147","author":"van der Ploeg","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaip.2019.07.004","article-title":"Skewed lymphocyte subpopulations and associated phenotypes in patients with mastocytosis","volume":"8","author":"Kulinski","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3324\/haematol.11558","article-title":"Biochemical markers predictive for bone marrow involvement in systemic mastocytosis","volume":"93","author":"Donker","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2013.06.019","article-title":"Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis","volume":"132","author":"Rabenhorst","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2021.02.023","article-title":"Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis","volume":"148","author":"G\u00fclen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V96.4.1267","article-title":"Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology","volume":"96","author":"Akin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib18","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jaip.2023.02.007","article-title":"Bone and cytokine markers associated with bone disease in systemic mastocytosis","volume":"11","author":"Rama","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","article-title":"IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis","volume":"115","author":"Brockow","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib21","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib22","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNF[alpha] facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3","volume":"96","author":"Tiziano","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood.V49.4.563.563","article-title":"Systemic mastocytosis in a patient with polycythemia vera treated with radioactive phosphorus","volume":"49","author":"Eagan","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.1987.tb05787.x","article-title":"Skin mast cells in polycythaemia vera relationship to the pathogenesis and treatment of pruritus","volume":"116","author":"Jackson","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib26","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1182\/blood-2008-09-179416","article-title":"Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders","volume":"113","author":"Ishii","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/0284186X.2017.1337926","article-title":"U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden","volume":"57","author":"Glimelius","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib28","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2009.149","article-title":"Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics","volume":"6","author":"Tefferi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/cells10061459","article-title":"A distinct faecal microbiota and metabolite profile linked to bowel habits in patients with irritable bowel syndrome","volume":"10","author":"Ahluwalia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Software"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib33","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Wiener","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13333","article-title":"No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis","volume":"99","author":"Rosell","year":"2024","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2023.07.001","article-title":"Increased TIM-3 and GAL-9 serum levels in patients with advanced systemic mastocytosis","volume":"152","author":"Konantz","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2022.04.023","article-title":"Massive release of T(H)2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosis","volume":"150","author":"Boehm","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12519","article-title":"LAG3 (CD223) as a cancer immunotherapy target","volume":"276","author":"Andrews","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib39","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.177.8.4991","article-title":"Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression1","volume":"177","author":"Chen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib40","first-page":"368","article-title":"Level of interleukin-18 binding protein is significantly different in patients with anaphylaxis than urticaria","volume":"40","author":"Kim","year":"2022","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1067\/mai.2002.120524","article-title":"Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase","volume":"109","author":"Brockow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/all.13981","article-title":"CD203c distinguishes the erythroid and mast cell-basophil differentiation trajectories among human Fc[epsilon]RI+ bone marrow progenitors","volume":"75","author":"Grootens","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000079731","article-title":"Serum basic fibroblast growth factor and vascular endothelial growth factor levels are related in patients with polycythaemia vera","volume":"112","author":"Theodoridou","year":"2004","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib44","first-page":"958","article-title":"Serum transferrin receptor in polycythemia","volume":"83","author":"Manteiga","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.788411","article-title":"Ectodysplasin A\/ectodysplasin A receptor system and their roles in multiple diseases","volume":"12","author":"Cai","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jmoldx.2024.05.010_bib46","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.2147\/JIR.S339254","article-title":"Progranulin as a potential therapeutic target in immune-mediated diseases","volume":"14","author":"Lan","year":"2021","journal-title":"J Inflamm Res"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T07:47:08Z","timestamp":1728546428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157824001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1525157824001302"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.05.010","relation":{},"ISSN":["1525-1578"],"issn-type":[{"type":"print","value":"1525-1578"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}